Georgios Antonios Margonis
- Oncology top 1%
- Hepatology top 0.5%
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology top 5%
- Co-authors
- Kazunari SasakiTimothy M. PawlikYuhree KimNikolaos AndreatosNeda AminiStefan BuettnerGaya SpolveratoMatthew J. Weiss
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (60 papers)Colorectal Cancer Treatments and Studies (46 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- United StatesGreeceGermany
In The Last Decade
Georgios Antonios Margonis
123 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 109
- Oncology 2.0k
- Hepatology 1.6k
- Surgery 1.5k
- Pulmonary and Respiratory Medicine 781
- Epidemiology 481
Countries citing papers authored by Georgios Antonios Margonis
This map shows the geographic impact of Georgios Antonios Margonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgios Antonios Margonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgios Antonios Margonis more than expected).
Fields of papers citing papers by Georgios Antonios Margonis
This network shows the impact of papers produced by Georgios Antonios Margonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgios Antonios Margonis. The network helps show where Georgios Antonios Margonis may publish in the future.
Co-authorship network of co-authors of Georgios Antonios Margonis
This figure shows the co-authorship network connecting the top 25 collaborators of Georgios Antonios Margonis. A scholar is included among the top collaborators of Georgios Antonios Margonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgios Antonios Margonis. Georgios Antonios Margonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 47 | |
| 8 | 17 | |
| 9 | 4 | |
| 10 | 32 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 111 | |
| 14 | 21 | |
| 15 | 11 | |
| 16 | 41 | |
| 17 | Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: A single center experience. | 6 |
| 18 | 7 | |
| 19 | 40 | |
| 20 | 34 |
About Georgios Antonios Margonis
Georgios Antonios Margonis is a scholar working on Hepatology, Oncology and Geriatrics and Gerontology, having authored 124 papers that have together received 3.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (60 papers), Colorectal Cancer Treatments and Studies (46 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers). The work is most often cited by research in Hepatology (1.6k citations), Oncology (2.0k citations) and Geriatrics and Gerontology (270 citations). Georgios Antonios Margonis has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Kazunari Sasaki, Timothy M. Pawlik, Yuhree Kim, Nikolaos Andreatos, Neda Amini, Timothy M. Pawlik, Stefan Buettner, Gaya Spolverato, Matthew J. Weiss and Efstathios Antoniou. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.